Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 5
2008 2
2009 4
2010 6
2011 11
2012 7
2013 2
2014 1
2015 2
2016 1
2017 5
2018 7
2019 4
2020 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacokinetic evaluation of roflumilast.
Lahu G, Nassr N, Hünnemeyer A. Lahu G, et al. Expert Opin Drug Metab Toxicol. 2011 Dec;7(12):1577-91. doi: 10.1517/17425255.2011.632409. Epub 2011 Nov 8. Expert Opin Drug Metab Toxicol. 2011. PMID: 22059647 Review.
An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.
Gilleen J, Farah Y, Davison C, Kerins S, Valdearenas L, Uz T, Lahu G, Tsai M, Ogrinc F, Reichenberg A, Williams SC, Mehta MA, Shergill SS. Gilleen J, et al. Among authors: lahu g. Psychopharmacology (Berl). 2021 May;238(5):1279-1289. doi: 10.1007/s00213-018-5134-y. Epub 2018 Dec 8. Psychopharmacology (Berl). 2021. PMID: 30536081 Free PMC article. Clinical Trial.
55 results